Future Prospects in Radiation Oncology from the Perspective of Innovative Radiation Biology

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2023 Nov 24

PMID 38001382

Authors

Franz Rodel

Udo Gaipl

Affiliations

Soon will be listed here.

References

Khozooei S, Veerappan S, Toulany M . YB-1 activating cascades as potential targets in KRAS-mutated tumors. Strahlenther Onkol. 2023; 199(12):1110-1127. DOI: 10.1007/s00066-023-02092-8. View

Classen S, Petersen C, Borgmann K . Crosstalk between immune checkpoint and DNA damage response inhibitors for radiosensitization of tumors. Strahlenther Onkol. 2023; 199(12):1152-1163. PMC: 10674014. DOI: 10.1007/s00066-023-02103-8. View

Schatz J, Ladinig A, Fietkau R, Putz F, Gaipl U, Frey B . Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines. Strahlenther Onkol. 2022; 199(12):1140-1151. PMC: 10673751. DOI: 10.1007/s00066-022-02028-8. View

Wittmann A, Bartels A, Alkotub B, Bauer L, Kafshgari M, Multhoff G . Chronic inflammatory effects of in vivo irradiation of the murine heart on endothelial cells mimic mechanisms involved in atherosclerosis. Strahlenther Onkol. 2023; 199(12):1214-1224. PMC: 10673733. DOI: 10.1007/s00066-023-02130-5. View

Szatmari T, Balazs K, Csordas I, Safrany G, Lumniczky K . Effect of radiotherapy on the DNA cargo and cellular uptake mechanisms of extracellular vesicles. Strahlenther Onkol. 2023; 199(12):1191-1213. DOI: 10.1007/s00066-023-02098-2. View

Weissmann T, Ruckert M, Putz F, Donaubauer A, Hecht M, Schnellhardt S . Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies. Strahlenther Onkol. 2023; 199(12):1164-1172. PMC: 10674008. DOI: 10.1007/s00066-022-02038-6. View

Helm A, Fournier C . High-LET charged particles: radiobiology and application for new approaches in radiotherapy. Strahlenther Onkol. 2023; 199(12):1225-1241. PMC: 10674019. DOI: 10.1007/s00066-023-02158-7. View

Scheper J, Hildebrand L, Faulhaber E, Deloch L, Gaipl U, Symank J . Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts. Strahlenther Onkol. 2022; 199(12):1128-1139. PMC: 10673781. DOI: 10.1007/s00066-022-02009-x. View

To N, Pilon C, Moatti A, Debesset A, Debbi K, Coraggio G . Effect of lethal total body irradiation on bone marrow chimerism, acute graft-versus-host disease, and tumor engraftment in mouse models: impact of different radiation techniques using low- and high-energy X-rays. Strahlenther Onkol. 2023; 199(12):1242-1254. DOI: 10.1007/s00066-023-02066-w. View

10.

Frey B, Borgmann K, Jost T, Greve B, Oertel M, Micke O . DNA as the main target in radiotherapy-a historical overview from first isolation to anti-tumour immune response. Strahlenther Onkol. 2023; 199(12):1080-1090. DOI: 10.1007/s00066-023-02122-5. View

11.

Viktorsson K, Rieckmann T, Fleischmann M, Diefenhardt M, Hehlgans S, Rodel F . Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy. Strahlenther Onkol. 2023; 199(12):1091-1109. PMC: 10673805. DOI: 10.1007/s00066-023-02064-y. View

12.

Becherini C, Lancia A, Detti B, Lucidi S, Scartoni D, Ingrosso G . Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review. Strahlenther Onkol. 2023; 199(12):1173-1190. PMC: 10673745. DOI: 10.1007/s00066-023-02097-3. View